{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:25:45Z","timestamp":1767990345055,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4882-8","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T08:24:10Z","timestamp":1540542250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery"],"prefix":"10.1186","volume":"18","author":[{"given":"Kevin W","family":"McCool","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Sampene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brock","family":"Polnaszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E","family":"Medlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-2414","authenticated-orcid":false,"given":"Lisa","family":"Barroilhet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"issue":"2","key":"4882_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4037\/ajcc2009193","volume":"18","author":"M Engoren","year":"2009","unstructured":"Engoren M, Arslanian-Engoren C. Long-term survival in the intensive care unit after erythrocyte blood transfusion. Am J Crit Care. 2009 Mar;18(2):124\u201331.","journal-title":"Am J Crit Care"},{"issue":"5","key":"4882_CR2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/01.TA.0000060261.10597.5C","volume":"54","author":"DL Malone","year":"2003","unstructured":"Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma. 2003 May;54(5):898\u2013905.","journal-title":"J Trauma"},{"key":"4882_CR3","doi-asserted-by":"crossref","unstructured":"Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;1.","DOI":"10.1002\/14651858.CD005033.pub2"},{"issue":"11","key":"4882_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/BF02552276","volume":"32","author":"J Beynon","year":"1989","unstructured":"Beynon J, Davies PW, Billings PJ, Channer JL, Protheroe D, Umpleby HC, Mortensen NJ, Williamson RC. Perioperative blood transfusion increases the risk of recurrence in colorectal cancer. Dis Colon Rectum. 1989 Nov;32(11):975\u20139.","journal-title":"Dis Colon Rectum"},{"issue":"5\u20136","key":"4882_CR5","first-page":"361","volume":"10","author":"L Burrows","year":"1987","unstructured":"Burrows L, Tartter P, Aufses A. Increased recurrence rates in perioperatively transfused colorectal malignancy patients. Cancer Detect Prev. 1987;10(5\u20136):361\u20139.","journal-title":"Cancer Detect Prev"},{"key":"4882_CR6","doi-asserted-by":"crossref","unstructured":"Nadeem R, Turkman B, Cha M. Impact of Perioperative Blood Transfusion on Survival Among Women with Breast Cancer. Am J Thera. 2017 May;16.","DOI":"10.1200\/JCO.2017.35.15_suppl.e21591"},{"issue":"6","key":"4882_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.eururo.2014.08.051","volume":"66","author":"EJ Abel","year":"2014","unstructured":"Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol. 2014 Dec;66(6):1139\u201347.","journal-title":"Eur Urol"},{"key":"4882_CR8","doi-asserted-by":"crossref","unstructured":"De Oliveira GS Jr, Schink JC, Buoy C, Ahmad S, Fitzgerald PC, McCarthy RJ. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer. Transfus Med 2012 Apr;22(2):97\u2013103.","DOI":"10.1111\/j.1365-3148.2011.01122.x"},{"issue":"2","key":"4882_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ygyno.2005.06.017","volume":"99","author":"NR Abu-Rustum","year":"2005","unstructured":"Abu-Rustum NR, Richard S, Wilton A, Lev G, Sonoda Y, Hensley ML, Gemignani M, Barakat RR, Chi DS. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Gynecol Oncol. 2005 Nov;99(2):320\u20136.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"4882_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"Ignace Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH,van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group.; NCIC Clinical Trials Group. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med 2010;363(10):943\u2013953.","journal-title":"New England Journal of Medicine"},{"issue":"9990","key":"4882_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","volume":"386","author":"S Kehoe","year":"2015","unstructured":"Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T, Luesley D, Perren T, Bannoo S, Mascarenhas M, Dobbs S, Essapen S, Twigg J, Herod J, McCluggage G, Parmar M, Swart AM. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet. 2015 Jul 18;386(9990):249\u201357.","journal-title":"Lancet"},{"issue":"3","key":"4882_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ygyno.2016.12.017","volume":"144","author":"R Kessous","year":"2017","unstructured":"Kessous R, Laskov I, Abitbol J, Bitharas J, Yasmeen A, Salvador S, Lau S, Gotlieb WH. Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol. 2017 Mar;144(3):474\u20139.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4882-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4882-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T19:07:41Z","timestamp":1572030461000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4882-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4882"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4882-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was submitted to the UW-Madison Institutional Review Board and granted exemption status.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare(s) that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1041"}}